ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.188,34
-1,00%
S&P 500
5.214,08
0,51%
US Dollar vs BRL
5,1423
0,00%
Bitcoin
62.856,53
-0,30%
Brent Oil
84,075
0,15%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. N4 Pharma Plc (N4P)

  7. N4 Pharma Plc (N4P) Notícias

N4P

N4 Pharma (N4P)

N4 Pharma Plc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:N4P
DataHoraFonteTítuloCódigoCompanhia
29/04/202406:59RNS Regulatory NewsN4 Pharma PLC Posting of Annual Report & Notice of AGMLSE:N4PN4 Pharma Plc
26/04/202403:00RNS Non-RegulatoryN4 Pharma PLC N4 Pharma Webinar on SRI CollaborationLSE:N4PN4 Pharma Plc
25/04/202407:56Alliance NewsAlliance NewsN4 Pharma strikes partnership deal for intracellular deliveryLSE:N4PN4 Pharma Plc
25/04/202403:38RNS Regulatory NewsN4 Pharma PLC Collaboration Agreement with SRI International IncLSE:N4PN4 Pharma Plc
23/04/202409:32Alliance NewsAlliance NewsIN BRIEF: N4 Pharma loss widens but "great optimism" remainsLSE:N4PN4 Pharma Plc
23/04/202403:00RNS Regulatory NewsN4 Pharma PLC Final ResultsLSE:N4PN4 Pharma Plc
18/04/202408:14Alliance NewsAlliance NewsN4 Pharma sees potential in Nuvec delivery method for cancer treatmentLSE:N4PN4 Pharma Plc
18/04/202403:00RNS Regulatory NewsN4 Pharma PLC Oral Delivery UpdateLSE:N4PN4 Pharma Plc
04/03/202412:13RNS Regulatory NewsN4 Pharma PLC Holding(s) in CompanyLSE:N4PN4 Pharma Plc
15/02/202409:06Alliance NewsAlliance NewsIN BRIEF: N4 Pharma shares rise on "encouraging" Nuvec researchLSE:N4PN4 Pharma Plc
15/02/202404:00RNS Regulatory NewsN4 Pharma PLC in-vitro siRNA updateLSE:N4PN4 Pharma Plc
19/01/202406:26Alliance NewsAlliance NewsIN BRIEF: N4 Pharma gets India patent for medical delivery systemLSE:N4PN4 Pharma Plc
19/01/202404:00UK RegulatoryN4 Pharma PLC Patent GrantLSE:N4PN4 Pharma Plc
16/01/202410:26Alliance NewsAlliance NewsIN BRIEF: N4 Pharma touts contract to test glaucoma treatment, ECP105LSE:N4PN4 Pharma Plc
16/01/202404:00UK RegulatoryN4 Pharma PLC Nanogenics UpdateLSE:N4PN4 Pharma Plc
08/01/202406:11Alliance NewsAlliance NewsN4 Pharma hails increased efficacy of Nuvec when complexed with AAV8LSE:N4PN4 Pharma Plc
08/01/202404:00UK RegulatoryN4 Pharma PLC AAV Viral Vector UpdateLSE:N4PN4 Pharma Plc
18/12/202309:43Alliance NewsAlliance NewsN4 Pharma rises on successful results from Nuvec administrationLSE:N4PN4 Pharma Plc
07/12/202315:28Alliance NewsAlliance NewsTRADING UPDATES: N4 Pharma hails "encouraging" siRNA researchLSE:N4PN4 Pharma Plc
07/12/202304:00UK RegulatoryN4 Pharma PLC Nuvec(R) R&D and Strategy UpdateLSE:N4PN4 Pharma Plc
01/12/202311:29Alliance NewsAlliance NewsTRADING UPDATES: N4 launches investor hub; Capricorn production fallsLSE:N4PN4 Pharma Plc
30/11/202306:00RNS Non-RegulatoryN4 Pharma PLC N4 Pharma Launches New Interactive Investor HubLSE:N4PN4 Pharma Plc
31/10/202304:00UK RegulatoryN4 Pharma PLC Total Voting RightsLSE:N4PN4 Pharma Plc
09/10/202303:00RNS Non-RegulatoryN4 Pharma PLC Investor Presentation via Investor Meet CompanyLSE:N4PN4 Pharma Plc
02/10/202303:00RNS Non-RegulatoryN4 Pharma PLC Investor PresentationLSE:N4PN4 Pharma Plc
28/09/202306:20Alliance NewsAlliance NewsN4 Pharma shares fall as places shares to fund Nanogenics stake buyLSE:N4PN4 Pharma Plc
28/09/202303:00UK RegulatoryN4 Pharma PLC Acquisition of Controlling Interest in NanogenicsLSE:N4PN4 Pharma Plc
12/09/202309:43Alliance NewsAlliance NewsN4 Pharma interim loss narrows slightly as business outreach ongoingLSE:N4PN4 Pharma Plc
12/09/202303:00UK RegulatoryN4 Pharma PLC Interim ResultsLSE:N4PN4 Pharma Plc
25/07/202306:12Alliance NewsAlliance NewsN4 Pharma shares soar on further patent grant for Nuvec in USLSE:N4PN4 Pharma Plc
 Apresentando as notícias mais relevantes sobre:LSE:N4P

Seu Histórico Recente

BOV
VVEO3
CM Hospitalar ON
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
TELB4
TELEBRAS PN
BOV
IBOV
Índice Bovespa
BOV
CASH3
Meliuz S.A ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
PRIO3
PETRORIO ON
BOV
COGN3
COGNA ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados